Leiner Sees Gross Margins Improve, Brings Manufacturing In-House
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' gross profit margins continue to improve, with consolidated gross profit margin "returning" to 24.5% for the fourth quarter of fiscal 2006, CEO Robert Kaminski announced during a fourth-quarter and full-year earnings call June 15
You may also be interested in...
Leiner OTC Sales Jump Nearly 30% On New Products, Manufacturing Promotions
Private labeler Leiner Health Products' OTC product sales increased by nearly 30% for its fiscal 2007 second quarter, driven largely by new product launches and promotions with manufacturing customers, COO Robert Reynolds said in a Nov. 14 analysts call
Leiner Posts Strong Q1 Sales Boosted By Joint, Heart Health Categories
Leiner Health Products' strong sales in the joint care, coenzyme Q10 and fish oil categories produced a 12.6% boost to $163.9 mil. in net sales for the first quarter of fiscal 2007 (ended June 24, 2006), the firm announced in a first quarter earnings call Aug. 8
Leiner Looks To Private Label VMS, Contract Manufacturing For Sales Boost
Leiner Health Products has "turned back on [its] new product engine" and is looking to the private label arena as it plans upcoming product introductions